A publication in Nature Reviews Urology summarizes the scientific basis for SelectImmune’s drug development strategy.
“Immunomodulation therapy offers new molecular strategies to treat urinary tract bacterial infections” – a publication in Nature Reviews Urology summarizes the scientific basis behind SelectImmune’s drug development strategy. The review also describes successful examples of innate immunomodulation therapy. Butler, D., Ambite, I., et al. Immunomodulation therapy offers new molecular strategies to treat UTI. Nature Reviews Urology (2022). DOI: 10.1038/s41585- 022-00602-4. Innovative solutions are needed for the treatment of bacterial infections and a range of